Onspira Therapeutics Patents – Insights & Stats (Updated 2023)

Onspira Therapeutics has a total of 17 patents globally, out of which 8 have been granted. Of these 17 patents, more than 94% patents are active. The USA is where Onspira Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the USA seems to be the main focused R&D center of Onspira Therapeutics and is also the origin country of the firm.

Onspira Therapeutics was founded in the year 2017. The company operates as a clinical-stage biopharmaceutical firm.

Do read about some of the most popular patents of Onspira Therapeutics which have been covered by us in this article and also you can find Onspira Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Onspira Therapeutics patent portfolio.

How many patents does Onspira Therapeutics have?

Onspira Therapeutics has a total of 17 patents globally. These patents belong to 6 unique patent families. Out of 17 patents, 16 patents are active.

How Many Patents did Onspira Therapeutics File Every Year?

Onspira Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOnspira Therapeutics Applications FiledOnspira Therapeutics Patents Granted
20221
202142
202021
201921
2018
20171
20161
201511
201411
20131

How many Onspira Therapeutics patents are Alive/Dead?

Worldwide Patents

Onspira Therapeutics Patent Portfolio

How Many Patents did Onspira Therapeutics File in Different Countries?

Onspira Therapeutics Worldwide Patent Filing

Countries in which Onspira Therapeutics Filed Patents

CountryPatents
United States Of America9
Australia5
Canada2
Europe1

Where are Research Centres of Onspira Therapeutics Patents Located?

The R&D Centres of patents filed by Onspira Therapeutics is in the US.

Most Cited Onspira Therapeutics Patent

US8637469B2 is the most popular patent in the Onspira Therapeutics portfolio. It has received 13 citations so far from companies like Therapeutica Borealis.

List of Onspira Therapeutics Patents

Onspira Therapeutics PatentsTitle
US11718853B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
US11091763B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
US10550389B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
US8940683B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
US8637469B2Rhinosinusitis Prevention And Therapy With Proinflammatory Cytokine Inhibitors
US20230210768A1An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology
US20220409627A1Treatment Of Lower Airways Disorders
US20220339099A1Compositions Of Interleukin-1 Receptor Antagonist
EP4153213A1An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology
AU2019203630B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
AU2017200228B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
AU2013270447B2Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
AU2021277585A1An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology
AU2020395766A1Treatment Of Lower Airways Disorders
CA2660519A1Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
CA3177366A1Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
US20140311482A1Rhinosinusitis Prevention And Therapy With Proinflammatory Cytokine Inhibitors

What are Onspira Therapeutics’ key innovation segments?

What Technologies are Covered by Onspira Therapeutics?

The chart below distributes patents filed by Onspira Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Onspira Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Onspira Therapeutics’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Onspira Therapeutics?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.